Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression-MedSci.cn

Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression

Zheng, NN; Zhou, M; Sun, F; Huai, MX; Zhang, Y; Qu, CY; Shen, F; Xu, LM

Xu, LM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Xinhua Hosp, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.

WORLD JOURNAL OF GASTROENTEROLOGY, 2020; 26 (26):

Abstract

BACKGROUND Immunotherapy targeting programmed death-1 (PD-1) or programmed death-ligand-1 (PD-L1) has been shown to be effective in a variety of malig......

Full Text Link